David Cordani - 23 Feb 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
Chair, President & CEO, Director
Signature
By: Jill M. Stadelman, attorney-in-fact
Issuer symbol
CI
Transactions as of
23 Feb 2022
Net transactions value
$0
Form type
4
Filing time
25 Feb 2022, 19:48:19 UTC
Previous filing
30 Nov 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +12,775 +9.1% $0.000000 152,752 23 Feb 2022 Direct F1, F2
holding CI Common Stock, $.01 Par Value 1,670 23 Feb 2022 By 401(k) F3
holding CI Common Stock, $.01 Par Value 370,915 23 Feb 2022 By GRAT F2
holding CI Common Stock, $.01 Par Value 39,795 23 Feb 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +57,284 $0.000000 57,284 23 Feb 2022 Common Stock, $.01 Par Value 57,284 $227.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2023.
F2 Reflects the transfer by the Reporting Person of 238,430 shares of common stock to a grantor retained annuity trust on November 18, 2021 and the transfer by the Reporting Person's grantor retained annuity trust of 104,736 shares of common stock in respect of the payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust on January 10, 2022.
F3 Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F4 This option vests in three equal annual installments beginning March 1, 2023.